Analysis of the survival curves from data obtained in the TCGA database indicated that patients with head and neck cancer with lower FOXM1 expression had significantly longer survival than those with higher FOXM1 expression (Figure 1F). This evidence concerns the gene FOXM1 and head and neck cancer.